{"product_id":"evidencebased-urology-9781119129882","title":"Evidencebased Urology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eAn updated and revised resource to evidence-based urology information and a guide for clinical practice\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe revised and updated second edition of \u003ci\u003eEvidence-Based Urology\u003c\/i\u003e offers the most current information on the suitability of both medical and surgical treatment options for a broad spectrum of urological conditions based on the best evidence available. The text covers each of the main urologic areas in specific sections such as general urology, oncology, female urology, trauma\/reconstruction, pediatric urology, etc. All the evidence presented is rated for quality using the respected GRADE framework. Throughout the text, the authors highlight the most patient-important, clinical questions likely to be encountered by urologists in day-to-day practice.\u003c\/p\u003e \u003cp\u003eA key title in the Evidence-Based series, this revised and expanded edition of \u003ci\u003eEvidence-Based Urology\u003c\/i\u003e contains new chapters on a variety of topics including: quality improvement, seminoma, nonseminomato\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003ci\u003e\"This is a valuable book for all who care for urological patients. Every provider should have a foundation in evidence-based medicine and be familiar with interpreting and applying clinical knowledge to patient care. This book helps readers to achieve both. It addresses today's most relevant clinical questions in a manner that enables readers to practice evidence-based medicine skills.\"\u003c\/i\u003e - \u003cb\u003eDoody's Book Review, April 2019\u003c\/b\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003ePart 1 Evidence‐based methods\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePhilipp Dahm\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1 Searching for evidence, 3\u003cbr\u003e\u003ci\u003eJeanette Buckingham\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Clinical trials in urology, 19\u003cbr\u003e\u003ci\u003eCharles D. Scales, Jr. and David F. Penson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Systematic reviews in urology, 25\u003cbr\u003e\u003ci\u003ePhilipp Dahm, Shahnaz Sultan, and Jae Hung Jung\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Rating the quality of evidence and making recommendations, 39\u003cbr\u003e\u003ci\u003ePhilipp Dahm and Shahnaz Sultan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Evidence‐based clinical practice guidelinesin urology, 47\u003cbr\u003e\u003ci\u003eSteven E. Canfield\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Understanding concepts related to health economics in urology, 53\u003cbr\u003e\u003ci\u003eYair Lotan and Ryan Hutchinson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Quality improvement in urology, 59\u003cbr\u003e\u003ci\u003eNima Almassi and Howard B. Goldman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 General urology and stone disease\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eCharles D. Scales, Jr.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Antibiotic prophylaxis in urological surgery, 67\u003cbr\u003e\u003ci\u003eRoderick Clark and Philippe Violette\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Venous thromboembolism (VTE) prophylaxis, 89\u003cbr\u003e\u003ci\u003eVikram Narayan and Philipp Dahm\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Operative safety, 103\u003cbr\u003e\u003ci\u003eElizabeth Timbrook Brown, Bryan J. Hill, and Roger R. Dmochowski\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Prophylaxis and treatment of urinary tract infections in adults, 113\u003cbr\u003e\u003ci\u003eGabrielle J. Williams, Angela C. Webster, and Jonathan C. Craig\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Medical management of stone disease, 133\u003cbr\u003e\u003ci\u003eTimothy Y. Tseng and Glenn M. Preminger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Surgical management of renal stone disease, 159\u003cbr\u003e\u003ci\u003eJustin M. Dersch, Brandon J. Otto, and Benjamin K. Canales\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Surgical management of ureteral stone disease, 171\u003cbr\u003e\u003ci\u003eAaron H. Lay, Jay D. Raman, and Margaret S. Pearle\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 Pediatric urology\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eLuis H.P. Braga\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Prenatal hydronephrosis, 187\u003cbr\u003e\u003ci\u003eShawn Dason and Luis H.P. Braga\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Cryptorchidism, 197\u003cbr\u003e\u003ci\u003eDavid I. Chu and Gregory E. Tasian\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Vesicoureteral reflux disease, 209\u003cbr\u003e\u003ci\u003eRuiyang Jiang and Jonathan C. Routh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Circumcision, 217\u003cbr\u003e\u003ci\u003eRoderick Clark and Sumit Dave\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Nocturnal enuresis, 235\u003cbr\u003e\u003ci\u003eStacy T. Tanaka\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Management of neurogenic bladder in children with spina bifida, 243\u003cbr\u003e\u003ci\u003eKourosh Afshar, Mir Sohail Fazeli, and Cyrus Chehroodi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Wilms tumor, 251\u003cbr\u003e\u003ci\u003eRuiyang Jiang and Jonathan C. Routh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4 Prostate cancer\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJulio M. Pow-Sang\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Early detection and screening for prostate cancer, 257\u003cbr\u003e\u003ci\u003ePim J. van Leeuwen, Monique J. Roobol, and Phillip D. Stricker\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Molecular markers for prostate cancer, 265\u003cbr\u003e\u003ci\u003ePranav Sharma, Eric Webb, and Julio M. Pow‐Sang\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Imaging of the prostate, 279\u003cbr\u003e\u003ci\u003eMatthew J. Watson, Francesca V. Mertan, Samuel Borofsky, Arvin K. George,Abhinav Sidana,\u003c\/i\u003e\u003ci\u003ePeter L. Choyke, Peter A. Pinto, and Baris Turkbey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Active surveillance for localized prostate cancer, 289\u003cbr\u003e\u003ci\u003eNathan Perlis and Laurence Klotz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Surgical management of prostate cancer,297\u003cbr\u003e\u003ci\u003eDaniel A. Barocas and Michael S. Cookson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Radiation therapy for clinically localized prostate cancer, 317\u003cbr\u003e\u003ci\u003eMichelle Echevarria, Peter A. Johnstone, and Kosj Yamoah\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 Management of metastatic prostate cancer, 331\u003cbr\u003e\u003ci\u003eMichael S. Humeniuk, Tian Zhang, Megan A. McNamara,Sundhar Ramalingam, and Michael R. Harrison\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 5 Kidney and bladder cancer\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRodney H. Breau\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 Treatment of superficial bladder cancer, 349\u003cbr\u003e\u003ci\u003eAlexander Kretschmer, Alexander Karl, and Badrinath R. Konety\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Treatment of muscle‐invasive bladder cancer, 367\u003cbr\u003e\u003ci\u003eJustin R. Gregg and Sam S. Chang\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31 Management of upper tract urothelial carcinoma, 373\u003cbr\u003e\u003ci\u003eIlaria Lucca, Romain Mathieu, Tobias Klatte, and Shahrokh F. Shariat\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 Metastatic bladder cancer, 383\u003cbr\u003e\u003ci\u003eLouise Harris, Caitlin Bowen, Satish Kumar, Bernadette Coles, and Malcolm Mason\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Treatment of localized kidney cancer, 391\u003cbr\u003e\u003ci\u003eLuke T. Lavallée, Frédérick Pouliot, and Rodney H. Breau\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Treatment of metastatic kidney cancer, 399\u003cbr\u003e\u003ci\u003ePrzemyslaw W. Twardowski and Robert A. Figlin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 6 Testis and penile cancer\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMichael C. Risk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Early‐stage (stage I) seminoma, 409\u003cbr\u003e\u003ci\u003eSia Daneshmand and Cory Hugen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 Advanced (stage II and III) and recurrent seminoma, 417\u003cbr\u003e\u003ci\u003ePeter C. Black and Christian Kollmannsberger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 Early‐stage nonseminomatous germ‑cell tumor, 427\u003cbr\u003e\u003ci\u003eJustin T. Matulay and James M. McKiernan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38 Advanced nonseminoma, 443\u003cbr\u003e\u003ci\u003eMichael C. Risk and Clint Cary\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e39 Penile cancer, 457\u003cbr\u003e\u003ci\u003eOliver W. Hakenberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 7 Female urology, trauma, and reconstruction\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRoger R. Dmochowski\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40 Medical management of urinary incontinence in women, 467\u003cbr\u003e\u003ci\u003eJoshua A. Cohn, Elizabeth Timbrook Brown, W. Stuart Reynolds, Melissa R. Kaufman,\u003c\/i\u003e\u003ci\u003eRoger R. Dmochowski\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41 Surgical treatment of female urinary incontinence, 479\u003cbr\u003e\u003ci\u003eAlex Gomelsky\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42 Diagnosis and treatment of overactive bladder, 489\u003cbr\u003e\u003ci\u003eNadir I. Osman, Altaf Mangera, and Christopher R. Chapple\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e43 Urethral stricture disease, 497\u003cbr\u003e\u003ci\u003eRobert A. Goldfarb and Sean P. Elliott\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e44 Genitourinary trauma, 503\u003cbr\u003e\u003ci\u003ePaul Chung and Bryan B. Voelzke\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 8 Male LUTS and sexual dysfunction\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJohn M. Hollingsworth\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e45 Medical management of benign prostatic hyperplasia, 511\u003cbr\u003e\u003ci\u003ePaholo G. Barboglio Romo and John M. Hollingsworth\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e46 Surgical management of lower urinary tract symptoms secondary to benign prostatic hypertrophy, 527\u003cbr\u003e\u003ci\u003eDerek J. Lomas and Amy Krambeck\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e47 Chronic prostatitis\/chronic pelvic pain syndrome (NIH category III), 539\u003cbr\u003e\u003ci\u003eGiuseppe Magistro and Florian M.E. Wagenlehner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e48 Management of erectile dysfunction, 545\u003cbr\u003e\u003ci\u003eHunter Wessells\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e49 Update on treatment of bladder pain syndrome: does anything work? 555\u003cbr\u003e\u003ci\u003eYahir Santiago‐Lastra, Ann Oldendorf, and J. Quentin Clemens\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e50 Male infertility, 561\u003cbr\u003e\u003ci\u003eBryan Hinck, Ashok Agarwal, Fnu Deepinder, and Edmund S. Sabanegh, Jr.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e51 Premature ejaculation, 569\u003cbr\u003e\u003ci\u003eJosip Vukina, J. Abram McBride, Culley C. Carson, and R. Matthew Coward\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 579\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49406993334615,"sku":"9781119129882","price":151.95,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119129882.jpg?v=1730497814","url":"https:\/\/bookcurl.com\/products\/evidencebased-urology-9781119129882","provider":"Book Curl","version":"1.0","type":"link"}